Introduction of foreign DNA into mycobacteria using a shuttle phasmid
The DOI matches its Crossref record.
Abstract
Mycobacteria are major pathogens of man and animals. There are approximately 10 million cases of tuberculosis world wide with an annual mortality of three million people. Leprosy, caused by Mycobacterium leprae, afflicts over ten million people, primarily in developing countries. M. tuberculosis and mycobacteria of the M. avium-intracellulare-scrofulaceum (MAIS) group are major opportunistic pathogens of patients with acquired immune deficiency syndrome (AIDS). M. paratuberculosis is the cause of Jöhne's disease in cattle. Yet, BCG (Bacille Calmette-Guerin), an avirulent strain of M. bovis, is the most widely used human vaccine in the world, having been administered to about 2.5 X 10(9) people since 1948 (ref. 4). BCG was highly protective against tuberculosis in England, but has been found not to be effective in preventing pulmonary tuberculosis in adults in Southern India. We have initiated studies to develop the methodology for efficient gene transfer in mycobacteria. We have constructed recombinant shuttle phasmids which are chimaeras containing mycobacteriophage DNA into which an E. coli cosmid is inserted. They can replicate in E. coli as plasmids and in mycobacteria as phages, and transfer DNA across both genera. These shuttle vectors permit for the first time the introduction of foreign DNA by infection into M. smegmatis and BCG. By introducing and ultimately expressing genes for protective antigens for a variety of pathogens, it may be possible to develop cultivatabl…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The shuttle phasmid replicates in E. coli as a plasmid and in mycobacteria as a phage (9, 11).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [9]
In the citing paper
“Foreign DNA was first introduced into mycobacteria in 1987 with a shuttle phasmid (9).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [9]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Research works printed but not linked: 1
- 1. Joint International Union Against Tuberculosis and World Health Organization Study Group Tubercle 63, 157–169 (1982). 2. Bloom, B. R. & Godal, T. Rev. infect. Dis. 5, 765–780 (1983). 3. Centers for Disease Control Morbid. Mortal, wkly. Rep. 34, 774 (1986). 4. United Nations Children's Emergency Fund (UNICEF) The State of the World's Children 131 (Oxford University Press, 1985). 5. Hart, P. D. & Sutherland, I. Br. Med. J. 2, 293–295 (1977). 6. Tuberculosis Prevention Trial, Madras Ind. J. med. Res. 72 (suppl.), 1–74 (1980). 7. Okanishi, M., Suzuki, K. & Umezawa, H. /. gen. Microbiol. 80, 389–400 (1974). 8. Hopwood, D. A. & Wright, H. M. Molec. Gen. Genet. 162, 307–317 (1978). 9. Bibb, M. J., Ward, J. M. & Hopwood, D. A. Nature 274, 398–400 (1978). 10. Crawford, J. T. & Bates, J. H. Infect. Immunity 24, 979–981 (1979). 11. Mizuguchi, Y., Fukunaga, M. & Taniguchi, H. /. Bact. 146, 656–659 (1981). 12. Meissner, P. S. & Falkinham, J. O. Ill J. Bact. 157, 669–672 (1984). 13. Labidi, A., David, H. L. & Roulland–Dussoix, D. Annls Microbiologie 136B, 209–215 (1985). 14. Brenner, S., Cesareni, G. & Karn, J. Gene 17, 27–44 (1982). 15. Suarez, J. E. & Chater, K. F. Nature 286, 527–529 (1980). 16. Timme, T. L. & Brennan, P. J. /. gen. Microbiol. 130, 2059–2066 (1984). 17. Collins, J. & Hohn, B. Proc. natn. Acad. Sci. U.S.A. 75, 4242–4246 (1978). 18. Hohn, B. & Collins, J. Gene 11, 291–298 (1980). 19. Lotte, A. et al. Adv. Tuberc. Res. 32, 107–193 (1984). 20. Hopwood, D. A. et al. In Genetic Manipulation of Streptomyces–A Laboratory Manual (John Innes Foundation, Norwich, 1985). 21. Froman, S., Will, D. W. & Bogen, E. Am. J. Public Health 44, 1326–1334 (1954). 22. Redmond, W. B. & Cater, J. C. Am. Rev. resp. Dis. 82, 781–787 (1960). 23. Udou, T., Ogawa, M. & Mizuguchi, Y. /. Bact. 151, 1035–1039 (1982). 24. Birnboim, H. C. & Doly, J. Nucleic Acids Res. 7, 1513–1525 (1979). 25. Benton, W. D. & Davis, R. W. Science 196, 180–182 (1977). 26. Southern, E. / molec. Biol. 98, 503–517 (1975). 27. Jones, W. D. Jr Tubercle, Lond. 60, 55–58 (1979). 28. Jones, W. D. Jr & Greenberg, J. /. din. Microbiol. 7, 467–469 (1978).
Cited by
New use of BCG for recombinant vaccines
Stover, C. K., de la Cruz, V. F., Fuerst, T. R., Burlein, J. E., Benson, L. A., Bennett, L. T., Bansal, G. P., Young, J. F., Lee, M. H., Hatfull, G. F., et al. (1991) · Nature · doi:10.1038/351456a0 · Cited by 1,490
Self-citationTuberculosis: Commentary on a Reemergent Killer
Bloom, B. R., & Murray, C. J. L. (1992) · Science · doi:10.1126/science.257.5073.1055 · Cited by 1,373
Self-citationSnapper, S. B., Melton, R. E., Mustafa, S., Kieser, T., & Jr, W. R. J. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02040.x · Cited by 1,237
Glickman, M. S., Cox, J. S., & Jacobs, W. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80250-6 · Cited by 655
“, 1997) as previously described (Bardarov et al., 1997; Jacobs et al., 1987) Acknowledgments and high titer phmsg78 prepared in M.”
BackgroundSelf-citationPhage Therapy for Antibiotic-Resistant Bacterial Infections
Hatfull, G. F., Dedrick, R. M., & Schooley, R. T. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-080219-122208 · Cited by 571
Jacobs, W. R., Barletta, R. G., Udani, R., Chan, J., Kalkut, G., Sosne, G., Kieser, T., Sarkis, G. J., Hatfull, G. F., & Bloom, B. R. (1993) · Science · doi:10.1126/science.8484123 · Cited by 439
Self-citation[25] Genetic systems for mycobacteria
Jacobs, W. R., Kalpana, G. V., Cirillo, J. D., Pascopella, L., Snapper, S. B., Udani, R. A., Jones, W., Barletta, R. G., & Bloom, B. R. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)04027-l · Cited by 433
Self-citationNontuberculous mycobacteria in the environment
Falkinham, J. O. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(02)00014-x · Cited by 434
Andersen, P. (1994) · Infection and Immunity · doi:10.1128/iai.62.6.2536-2544.1994 · Cited by 416
“, BCG (20, 41), and (ii) investigation of antigens secreted from the live bacteria during growth as a possible source of protective antigens (1, 5).”
BackgroundLee, M. H., Pascopella, L., Jacobs, W. R., & Hatfull, G. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3111 · Cited by 412
Self-citationMechanisms of Drug Resistance in Mycobacterium tuberculosis
Heym, B., Philipp, W., & Cole, S. T. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-80166-2_3 · Cited by 379
Microbial Pathogenesis of Mycobacterium tuberculosis: Dawn of a Discipline
Glickman, M. S., & Jacobs, W. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00236-7 · Cited by 352
Self-citationThe Mechanism of Isoniazid Killing: Clarity Through the Scope of Genetics
Vilchèze, C., & Jacobs, Jr. (2007) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.111606.122346 · Cited by 335
Self-citationLysogeny and transformation in mycobacteria: stable expression of foreign genes.
Snapper, S. B., Lugosi, L., Jekkel, A., Melton, R. E., Kieser, T., Bloom, B. R., & Jacobs, W. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6987 · Cited by 326
Self-citationHumoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines
Aldovini, A., & Young, R. A. (1991) · Nature · doi:10.1038/351479a0 · Cited by 313
Rationale for the Development of an Engineered Sporozoite Malaria Vaccine
Nussenzweig, V., & Nussenzweig, R. S. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60695-1 · Cited by 295
Bardarov, S., Kriakov, J., Carriere, C., Yu, S., Vaamonde, C., McAdam, R. A., Bloom, B. R., Hatfull, G. F., & Jacobs, W. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10961 · Cited by 278
Self-citationStover, C. K., Bansal, G. P., Hanson, M. S., Burlein, J. E., Palaszynski, S. R., Young, J. F., Koenig, S., Young, D. B., Sadziene, A., & Barbour, A. G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.197 · Cited by 267
“As a widely used human vaccine against tuberculosis, the live attenuated BCG vaccine also offers considerable advantages for development as a multivalent vaccine vehicle for other human pathogens (4).”
BackgroundHatfult, G. F., & Sarkis, G. J. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01131.x · Cited by 226
“Recently, however, progress has been made in the development of transformation systems (Jacobs et al., 1987), phasmid and plasmid vectors (Snapper ef al.”
BackgroundTransposition of an antibiotic resistance element in mycobacteria
Martin, C., Timm, J., Rauzier, J., Gomez-Lus, R., Davies, J., & Gicquel, B. (1990) · Nature · doi:10.1038/345739a0 · Cited by 222
McAdam, R. A., Weisbrod, T. R., Martin, J., Scuderi, J. D., Brown, A. M., Cirillo, J. D., Bloom, B. R., & Jacobs, W. R. (1995) · Infection and Immunity · doi:10.1128/iai.63.3.1004-1012.1995 · Cited by 208
“The combination of the knowledge of the entire sequence of L5 (18) and shuttle phasmid technologies (21) should offer a powerful means of delivering transposons efficiently to mycobacteria.”
BackgroundSelf-citationAndersen, A. B., & Hansen, E. B. (1989) · Infection and Immunity · doi:10.1128/iai.57.8.2481-2488.1989 · Cited by 183
“Currently, tools are being developed allowing genetic manipulation of mycobacteria (14, 28).”
Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis
Zhang, Y., Lathigra, R., Garbe, T., Catty, D., & Young, D. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb02120.x · Cited by 182
Zhang, Y., Garbe, T., & Young, D. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01596.x · Cited by 179
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future
Łobocka, M., Dąbrowska, K., & Górski, A. (2021) · BioDrugs · doi:10.1007/s40259-021-00480-z · Cited by 175
“coli as a plasmid and propagate in Mycobacterium as a phage, was constructed by the insertion of a cosmid into a non-essential ~ 50-kbp region of mycobacteriophage DNA [176].”
BackgroundCloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen
Matsuo, K., Yamaguchi, R., Yamazaki, A., Tasaka, H., & Yamada, T. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.9.3847-3854.1988 · Cited by 168
“bovis BCG with mycobacteriophage has recently been reported (15).”
BackgroundGene replacement and expression of foreign DNA in mycobacteria
Husson, R. N., James, B. E., & Young, R. A. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.2.519-524.1990 · Cited by 167
“We and our colleagues (11, 18) have developed methods for molecular genetic manipulation of mycobacteria because of our interest in its biology and because of its potential use as a vaccine vehicle.”
MethodLangermann, S., Palaszynski, S., Sadziene, A., Stover, C. K., & Koenig, S. (1994) · Nature · doi:10.1038/372552a0 · Cited by 166
Garbe, T., Harris, D., Vordermeier, M., Lathigra, R., Ivanyi, J., & Young, D. (1993) · Infection and Immunity · doi:10.1128/iai.61.1.260-267.1993 · Cited by 164
“The recent development of techniques and vectors for transformation of mycobacteria (14, 21, 23, 24) has been stimulated by the goal of creating a new generation of recombinant Mycobacterium bovis BCG vaccines (1, 14, 25).”
BackgroundPermeability of the cell wall of Mycobacterium smegmatis
Trias, J., & Benz, R. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb01289.x · Cited by 164
The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis
Vilchèze, C., & Jacobs, W. R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.016 · Cited by 160
Self-citationDonnelly‐Wu, M. K., Jacobs, W. R., & Hatfull, G. F. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01132.x · Cited by 160
Self-citationRanes, M. G., Rauzier, J., Lagranderie, M., Gheorghiu, M., & Gicquel, B. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.5.2793-2797.1990 · Cited by 159
Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome
Collins, F. M. (1989) · Clinical Microbiology Reviews · doi:10.1128/cmr.2.4.360 · Cited by 157
Mycobacterium smegmatis: The Vanguard of Mycobacterial Research
Sparks, I. L., Derbyshire, K. M., Jacobs, W. R., & Morita, Y. S. (2023) · Journal of Bacteriology · doi:10.1128/jb.00337-22 · Cited by 149
Self-citationInsertional mutagenesis and illegitimate recombination in mycobacteria.
Kalpana, G. V., Bloom, B. R., & Jacobs, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5433 · Cited by 152
Self-citationAllelic exchange in Mycobacterium tuberculosis with long linear recombination substrates
Balasubramanian, V, Pavelka, M. S., Bardarov, S. S., Martin, J., Weisbrod, T. R., McAdam, R. A., Bloom, B. R., & Jacobs, W. R. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.1.273-279.1996 · Cited by 150
Self-citationRecombineering mycobacteria and their phages
van Kessel, J. C., Marinelli, L. J., & Hatfull, G. F. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro2014 · Cited by 168
“tuberculosis , including shuttle-phasmid developmen”
Smet, K. A. L. D., Kempsell, K. E., Gallagher, A., Duncan, K., & Young, D. B. (1999) · Microbiology · doi:10.1099/00221287-145-11-3177 · Cited by 144
“Stable transformation of mycobacteria with plasmid constructs was first reported by Jacobs et al. (1987) .”
BackgroundMOLECULAR BIOLOGY OF THE MYCOBACTERIA
Colston, M. J., & Lamb, F. I. (1989) · Leprosy Review · doi:10.5935/0305-7518.19890011 · Cited by 146
Mechanisms of Drug Resistance in Mycobacterium tuberculosis
Cole, S. T. (1994) · Immunobiology · doi:10.1016/s0171-2985(11)80466-3 · Cited by 140
Wei, J., Dahl, J. L., Moulder, J. W., Roberts, E. A., Gaora, P. Ó., Young, D. B., & Friedman, R. L. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.2.377-384.2000 · Cited by 151
“Mycobacterium smegmatis was selected for use in these studies because it grows rapidly in the laboratory, readily expresses genes from other mycobacteria ( 20 , 40, 44), and can be genetically manipulated by various techniques (21).”
BackgroundActinobacteriophages: Genomics, Dynamics, and Applications
Hatfull, G. F. (2020) · Annual Review of Virology · doi:10.1146/annurev-virology-122019-070009 · Cited by 135
The Secret Lives of Mycobacteriophages
Hatfull, G. F. (2012) · Advances in virus research · doi:10.1016/b978-0-12-394621-8.00015-7 · Cited by 149
A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein.
Mehra, V. L., Bloom, B. R., Bajardi, A., Grisso, C. L., Sieling, P. A., Alland, D., Convit, J., Fan, X. D., Hunter, S. W., & Brennan, P. J. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.1.275 · Cited by 131
Self-citationBhatt, A., Kremer, L., Dai, A. Z., Sacchettini, J. C., & Jacobs, W. R. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.22.7596-7606.2005 · Cited by 126
“An added advantage is that gene knockouts are generated using a temperature-sensitive shuttle phasmid (3, 4, 8, 18) derived from the lytic phage TM4 (45), which has a wide host range within mycobacterial species (14), allowing the method to be easily adapted to other mycobacteria.”
BackgroundSelf-citationMycobacteriophages: Genes and Genomes
Hatfull, G. F. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134233 · Cited by 140
Daugelat, S., Kowall, J., Mattow, J., Bumann, D., Winter, R., HURWITZ, R. M., & Kaufmann, S. H. E. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00205-3 · Cited by 137
Langermann, S., Palaszynski, S., Burlein, J. E., Koenig, S., Hanson, M. S., Briles, D. E., & Stover, C. K. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.6.2277 · Cited by 119
“Recently developed genetic systems for the expression of foreign antigens in mycobacteria (25-28) have enabled the evaluation of rBCG as a vaccine delivery vehicle.”
Piuri, M., Jacobs, W. R., & Hatfull, G. F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004870 · Cited by 120
“Although luciferase reporter mycobacteriophages have been derived from phages TM4, D29, L5, and Che12 [9,15–17], we chose to construct and evaluate fluorophage derivatives of TM4 [18,19], since shuttle phasmid derivatives of TM4 are relatively simple to manipulate [20,21], conditionally-replicating mutants of TM4 are…”
MethodSelf-citationHatfull, G. F. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0026-2018 · Cited by 112
“An important breakthrough in the late 1980’s occurred when it was demonstrated that phage DNA could be taken up by mycobacterial spheroplasts, followed by conversion into infectious units and plaque formation (12).”
BackgroundCarrière, C., Riska, P. F., Zimhony, O., Kriakov, J., Bardarov, S., Burns, J., Chan, J., & Jacobs, W. R. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.12.3232-3239.1997 · Cited by 118
“However, TM4-derived phages repropagated from single plaques on BCG (occurring at a frequency of less than 10(28)) (9) are able to efficiently plaque on BCG, while retaining their plaquing on M.”
BackgroundMethodSelf-citationRecombineering: A powerful tool for modification of bacteriophage genomes
Marinelli, L. J., Hatfull, G. F., & Piuri, M. (2012) · Bacteriophage · doi:10.4161/bact.18778 · Cited by 107
Mycobacteriophages: Windows into Tuberculosis
Hatfull, G. F. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003953 · Cited by 103
Levin, M. E., & Hatfull, G. F. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01572.x · Cited by 126
Pascopella, L., Collins, F. M., Martin, J., Lee, M., Hatfull, G. F., Stover, C. K., Bloom, B. R., & Jacobs, W. R. (1994) · Infection and Immunity · doi:10.1128/iai.62.4.1313-1319.1994 · Cited by 100
“The ability to transfer and express recombinant DNA among the mycobacteria, which has been recently demonstrated (11, 20), enables the usage of molecular genetics to elucidate pathogenic mechanisms.”
BackgroundSelf-citationComplete nucleotide sequence of pAL5OOO, a plasmid from Mycobacterium fortuitum
Rauzier, J., Moniz-Pereira, J., & Gicquel-Sanzey, B. (1988) · Gene · doi:10.1016/0378-1119(88)90048-0 · Cited by 98
Molecular Genetics of Mycobacteriophages
Hatfull, G. F. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0032-2013 · Cited by 120
“…roadblocks, in part because of the ability to introduce phage DNA into M. smegmatis spheroplasts using strategies developed earlier for Streptomyces (42, 43) and because of the development of shuttle phasmids, which grow as phages in mycobacteria and as large plasmids in Escherichia coli (44, 45).”
MethodA novel transposon trap for mycobacteria: isolation and characterization of IS1096
Cirillo, J. D., Barletta, R. G., Bloom, B. R., & Jacobs, W. R. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.24.7772-7780.1991 · Cited by 99
“There now exist a wide range of shuttle phasmid (18), shuttle plasmid (30, 35), and integration-proficient (21) vectors that can be used to transfer recombinant DNA between Escherichia coli and both fast- and slow-growing species of mycobacteria.”
BackgroundSelf-citationReyrat, J., Berthet, F.-X., & Gicquel, B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8768 · Cited by 113
Bacteriophage–Host Interactions and the Therapeutic Potential of Bacteriophages
Dicks, L. M. T., & Vermeulen, W. (2024) · Viruses · doi:10.3390/v16030478 · Cited by 115
“…engineering of phages may be performed in several ways and includes recombination between phage DNA and plasmids [198], the use of shuttle plasmids [199], cloning of specific genes [200], recombineering [201,202], CRISPR-Cas selection [202], and a combination of recombineering and CRISPR-mediated…”
BackgroundMycobacteriophage TM4: genome structure and gene expression
Ford, M. E., Stenström, C. M., Hendrix, R. W., & Hatfull, G. F. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0007 · Cited by 98
Experiences with vaccines against cutaneous leishmaniasis: of men and mice
Modabber, F. Z. (1989) · Parasitology · doi:10.1017/s0031182000072243 · Cited by 93
Conjugal transfer of chromosomal DNA in Mycobacterium smegmatis
Parsons, L. M., Jankowski, C. S., & Derbyshire, K. M. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00818.x · Cited by 92
“Transduction and transformation systems are currently used to move DNA into different mycobacterial strains; however, each has its limitations (Jacobs et al., 1987; Snapper et al., 1988; 1990; Hatfull, 1993).”
BackgroundOhara, N., & Yamada, T. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00155-4 · Cited by 91
Recombinant Mycobacterium bovis BCG
Bastos, R. G., Borsuk, S., Seixas, F. K., & Dellagostin, O. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.044 · Cited by 113
“[17] developed an Escherichia coli-mycobacteria shuttle phasmid.”
Foley-Thomas, E. M., Whipple, D. L., Bermudez, L. E., & Barletta, R. G. (1995) · Microbiology · doi:10.1099/13500872-141-5-1173 · Cited by 95
Bharati, B. K., Sharma, I. M., Kasetty, S., Kumar, M., Mukherjee, R., & Chatterji, D. (2012) · Microbiology · doi:10.1099/mic.0.053892-0 · Cited by 109
“M. smegmatis is a non-pathogenic fast-growing species that is widely accepted as an excellent model system for studying various aspects of M. tuberculosis biology (Jacobs et al., 1987; Smeulders et al., 1999; Ojha et al., 2000; Dahl et al., 2005).”
BackgroundComparative genomics of the mycobacteriophages: insights into bacteriophage evolution
Hatfull, G. F., Cresawn, S. G., & Hendrix, R. W. (2008) · Research in Microbiology · doi:10.1016/j.resmic.2008.04.008 · Cited by 88
“TM4) may also have recombination systems, even though no recombination genes have been identified in their genomes [24].”
BackgroundHost Cell Targets of Released Lipid and Secreted Protein Effectors of Mycobacterium tuberculosis
Augenstreich, J., & Briken, V. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.595029 · Cited by 93
“This changed in the early 1990s when pioneering work established the first tools to allow foreign gene expression inmycobacteria (Jacobs et al., 1987; Ranes et al., 1990) and to create a specific gene deletion mutant (Bardarov et al.”
BackgroundFiss, E. H., Yu, S., & Jacobs, W. R. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb02189.x · Cited by 82
Self-citationPresent epidemiology of tuberculosis. Prevention and control programs
Orcau, À., Caylà, J. A., & Martínez, J. A. B. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(11)70011-8 · Cited by 106
Hansson, M., Ståhl, S., Nguyen, T. N., Bächi, T., Robert, A., Binz, H., Sjölander, A., & Uhlén, M. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.13.4239-4245.1992 · Cited by 80
“, vaccinia virus (23), adenovirus (4), poliovirus (9), and herpesvirus (28), or to bacterial systems such as salmonellae (13), mycobacteria (17), and Escherichia coli (25).”
BackgroundThe Pathogenesis of Tuberculosis
Schluger, N. W. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.f293 · Cited by 80
Mycobacteriophages: From Petri dish to patient
Hatfull, G. F. (2022) · PLOS Pathogens · doi:10.1371/journal.ppat.1010602 · Cited by 74
Broussard, G. W., & Ennis, D. G. (2006) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2006.07.012 · Cited by 85
The role of ribosomal RNAs in macrolide resistance
Sander, P., Prammananan, T., Meier, A., Frischkorn, K., & Böttger, E. C. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.5811946.x · Cited by 75
“Despite many efforts in mycobacterial genetics, only a limited number of selection markers [kanamycin (Jacobs et al., 1987), pyrF (Husson et al., 1990), hygromycin (Garbe et al., 1994), sacB (Pelicic et al., 1996), apramycin (Paget and Davies, 1996) and streptomycin/spectinomycin (Baulard et al.,…”
BackgroundCluster K Mycobacteriophages: Insights into the Evolutionary Origins of Mycobacteriophage TM4
Pope, W. H., Ferreira, C. M., Jacobs-Sera, D., Benjamin, R. C., Davis, A. J., DeJong, R. J., Elgin, S. C. R., Guilfoile, F. R., Forsyth, M. H., Harris, A. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026750 · Cited by 73
“Mycobacteriophage TM4 plays a central role in mycobacterial genetics, being the first phage to be used for shuttle phasmid construction [15] and still widely employed for efficient gene delivery to M.”
BackgroundSelf-citationChapter 6: Mycobacterium: Isolation, Maintenance, Transformation, and Mutant Selection
Connell, N. D. (1995) · Methods in cell biology · doi:10.1016/s0091-679x(08)61848-8 · Cited by 77
Construction of D29 shuttle phasmids and luciferase reporter phages for detection of mycobacteria
Pearson, R. E., Jurgensen, S. R., Sarkis, G. J., Hatfull, G. F., & Jacobs, W. R. (1996) · Gene · doi:10.1016/s0378-1119(96)00530-6 · Cited by 74
Self-citationConstruction and characterization of a Mycobacterium-Escherichia coli shuttle vector
Radford, A. J., & Hodgson, A. L. M. (1991) · Plasmid · doi:10.1016/0147-619x(91)90029-v · Cited by 68
Ami, Y., Izumi, Y., Matsuo, K., Someya, K., Kanekiyo, M., Horibata, S., Yoshino, N., Sakai, K., Shinohara, K., Matsumoto, S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12871-12879.2005 · Cited by 67
Genetic methods for deciphering virulence determinants of Mycobacterium tuberculosis
Braunstein, M., Bardarov, S., & Jacobs, W. R. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)58081-2 · Cited by 80
Self-citationSpringer, B., Sander, P., Sedlacek, L., Ellrott, K., & Böttger, E. C. (2001) · International Journal of Medical Microbiology · doi:10.1016/s1438-4221(01)80004-7 · Cited by 67
Panas, M. W., Jain, P., Yang, H., Mitra, S., Biswas, D., Wattam, A. R., Letvin, N. L., & Jacobs, W. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414207111 · Cited by 62
Self-citationSampson, T., Broussard, G. W., Marinelli, L. J., Jacobs-Sera, D., Ray, M., Ko, C.-C., Russell, D., Hendrix, R. W., & Hatfull, G. F. (2009) · Microbiology · doi:10.1099/mic.0.030486-0 · Cited by 62
“A variety of phage-derived tools have been described, including shuttle phasmids (Jacobs et al., 1987) that can be used to efficiently deliver transposons (Bardarov et al., 1997), reporter genes (Jacobs et al., 1993; Piuri et al., 2009), allelic-exchange substrates (Bardarov et al., 2002), and…”
The relA Homolog of Mycobacterium smegmatis Affects Cell Appearance, Viability, and Gene Expression
Dahl, J. L., Arora, K., Boshoff, H. I., Whiteford, D. C., Pacheco, S. A., Walsh, O. J., Lau-Bonilla, D., Davis, W. B., & Garza, A. G. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2439-2447.2005 · Cited by 65
Cirillo, J. D., Weisbrod, T. R., Pascopella, L., Bloom, B. R., & Jacobs, W. R. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00342.x · Cited by 61
Self-citationConstruction of shuttle vectors for genetic manipulation and molecular analysis of mycobacteria
Jain, S., Kaushal, D., Dasgupta, S. K., & Tyagi, A. K. (1997) · Gene · doi:10.1016/s0378-1119(96)00746-9 · Cited by 62
“Plasmids and integration proficient vectors based on sequences derived from mycobacteriophages have enabled stable introduction and expression of genes in mycobacteria (Jacobs et al., 1987; Lee et al., 1991; Stover et al., 1991).”
BackgroundKumar, M., & Chatterji, D. (2008) · Microbiology · doi:10.1099/mic.0.2008/017806-0 · Cited by 73
“M. smegmatis, a non-pathogenic fast-growing species, has been widely accepted as an excellent model system for studying various aspects of M. tuberculosis biology (Jacobs et al., 1987; Smeulders et al., 1999; Ojha et al., 2000; Dahl et al., 2005).”
BackgroundRetractedDasgupta, S. K., Jain, S., Kaushal, D., & Tyagi, A. K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8724 · Cited by 58
Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis
Allué‐Guardia, A., Saranathan, R., Chan, J., & Torrelles, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020735 · Cited by 67
“coli plasmids and mycobacteriophages paved the way for recombinant DNA research in mycobacteria [51], and contributed to the subsequent development of mycobacteriophage-based methods for the genetic manipulation of mycobacterial DNA.”
Control of Cell Wall Assembly by a Histone-Like Protein in Mycobacteria
Katsube, T., Matsumoto, S., Takatsuka, M., Okuyama, M., Ozeki, Y., Naito, M., Nishiuchi, Y., Fujiwara, N., Yoshimura, M., Tsuboi, T., et al. (2007) · Journal of Bacteriology · doi:10.1128/jb.00550-07 · Cited by 61
“procedure (17, 39), and then a hygromycin-resistant colony was selected.”
MethodTB: the return of the phage. A review of fifty years of mycobacteriophage research.
McNerney, R. (1999) · PubMed · Cited by 55
Tuberculosis: The Return of an Old Enemy
Collins, F. M. (1993) · Critical Reviews in Microbiology · doi:10.3109/10408419309113520 · Cited by 62
Leprosy, tuberculosis, and the new genetics
Young, D. B., & Cole, S. T. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.1.1-6.1993 · Cited by 65
“Widespread use of BCG has demonstrated its safety, and its potent immunogenicity has led to a suggested use as a carrier to vaccinate against other diseases (25).”
BackgroundThe Genus Mycobacterium--Nonmedical
Hartmans, S., & de Bont, J. A. M. (2011) · Springer eBooks · doi:10.1007/springerreference_3710 · Cited by 56
Inactivation of lsr2 Results in a Hypermotile Phenotype in Mycobacterium smegmatis
Arora, K., Whiteford, D. C., Lau-Bonilla, D., Davitt, C. M., & Dahl, J. L. (2008) · Journal of Bacteriology · doi:10.1128/jb.00023-08 · Cited by 59
Gulle, H., Schoel, B., & Kaufmann, S. H. E. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90366-4 · Cited by 53
Production of recombinant proteins in Mycobacterium smegmatis for structural and functional studies
Bashiri, G., & Baker, E. N. (2014) · Protein Science · doi:10.1002/pro.2584 · Cited by 66
Metadata
- Authors
- Jacobs, W. R., Tuckman, M., & Bloom, B. R.
- Affiliations
- Albert Einstein College of Medicine (US)
- Venue
- Nature
- Published
- 1987-06-11
- Volume
- 327
- Issue
- 6122
- Pages
- 532-535
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2045944193
- Cited by
- 314
- References
- 0
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 2 · 2021: 8 · 2020: 12 · 2019: 7 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 7 · 2014: 17 · 2013: 7 · 2012: 10
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- mycobacteria, shuttle vector, gene transfer, Mycobacterium smegmatis, BCG, recombinant phage, protective antigen, tuberculosis, leprosy, Mycobacterium avium subsp. paratuberculosis
- MeSH terms
- Bacteriophages, Cloning, Molecular, DNA Replication, DNA, Bacterial, DNA, Recombinant, Genetic Engineering, Genetic Vectors, Mycobacterium, Plasmids, Transfection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.